Earnings Ahead

HALO - Halozyme Therapeutics, Inc.

34.2 -0.64 -1.84

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HALO



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Halozyme Therapeutics Non-GAAP EPS of $0.82 misses by $0.01, revenue of $230.04M misses by $1.1M
  • Halozyme Therapeutics Q4 2023 Earnings Preview
  • J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma
  • EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
  • Lipocine licenses Tlando testosterone therapy to Verity Pharma
  • Regeneron’s high-dose Eylea, argenx’s Vyvgart injectable among latest approvals in Japan
  • Halozyme’s early 2023 results indicate a mixed performance
  • Halozyme gains as U.S. and EU clear Enhanze-based products
  • Top overweight stocks with high free cash flow and EPS growth - MS
  • JNJ multiple myeloma therapy outperforms standard of care by 58%
  • argenx slips as autoimmune disorder therapy fails in pivotal trial
  • Teva gains U.S. approval for generic version of osteoporosis injection
  • Argenx Vyvgart injectable granted EU nod for myasthenia gravis
  • Halozyme Therapeutics Non-GAAP EPS of $0.75 beats by $0.04, revenue of $216M in-line
  • Halozyme, Acumen enter collaboration for Alzheimer's drug candidate
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Halozyme Therapeutics Q3 2023 Earnings Preview
  • Bristol Myers succeeds in Phase 3 trial for subcutaneous Opdivo
  • Roche granted U.K. approval for subcutaneous Tecentriq
  • Halozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.10, revenue of $221.04M beats by $21.09M
PEERS
/XLV

XLV

Date Price Open High Low Vol Change ER
Oct 9, 2023 37.04 37.08
37.23
36.37
426K -0.62%
Oct 6, 2023 37.27 37.21
37.91
37.03
700K -1.01%
Oct 5, 2023 37.65 36.85
38.04
36.85
690K 1.10%
Oct 4, 2023 37.24 37.61
37.88
36.97
602K -1.09%
Oct 3, 2023 37.65 37.59
38.11
37.02
820K -0.11%
 
Oct 2, 2023 37.69 38.16
38.2
37.3
904K -1.34%
Sep 29, 2023 38.2 39.25
39.5
38.15
914K -2.43%
Sep 28, 2023 39.15 38.41
39.38
38.18
643K 1.82%
Sep 27, 2023 38.45 38.51
39.26
38.23
848K -0.05%
Sep 26, 2023 38.47 38.88
39.3
38.14
769K -1.08%
Sep 25, 2023 38.89 39.42
39.42
38.46
702K -1.72%
Sep 22, 2023 39.57 39.91
40.18
39.29
580K -0.85%
Sep 21, 2023 39.91 39.33
40.54
39
786K 0.78%
Sep 20, 2023 39.6 39.77
40.29
39.58
628K -0.43%
Sep 19, 2023 39.77 39.18
39.92
38.88
616K 1.69%
Sep 18, 2023 39.11 39.22
39.49
38.21
721K -0.28%
Sep 15, 2023 39.22 40.52
40.52
38.97
2.7M -3.21%
Sep 14, 2023 40.52 41.42
41.61
40.38
936K -1.24%
Sep 13, 2023 41.03 38.82
41.5
38.82
1.3M 5.42%
Sep 12, 2023 38.92 37.62
39.06
37.47
902K 3.79%
Sep 11, 2023 37.5 38.55
38.86
37.43
1.2M -2.62%
Sep 8, 2023 38.51 39.11
39.39
38.29
980K -1.61%
Sep 7, 2023 39.14 40.94
41.92
39.08
1.0M -4.58%
Sep 6, 2023 41.02 41.09
41.15
40.35
845K 0.29%
Sep 5, 2023 40.9 42.58
42.58
40.83
914K -4.48%
Sep 1, 2023 42.82 42.85
43.33
42.59
511K 0.61%
Aug 31, 2023 42.56 43.1
43.33
42.42
717K -0.98%
Aug 30, 2023 42.98 43.07
43.27
42.37
705K -0.28%
Aug 29, 2023 43.1 42.54
43.26
42.26
600K 1.56%
Aug 28, 2023 42.44 42.75
43.13
42.29
411K -0.59%
Aug 25, 2023 42.69 42.43
42.88
42.36
637K 1.07%
Aug 24, 2023 42.24 41.76
42.36
41.61
792K 0.67%
Aug 23, 2023 41.96 42.81
43.17
41.94
703K -1.73%
Aug 22, 2023 42.7 42.56
43.05
42.14
763K 0.19%
Aug 21, 2023 42.62 43.24
43.39
42.35
695K -1.48%
Aug 18, 2023 43.26 42.17
43.92
41.93
786K 1.84%
Aug 17, 2023 42.48 43.29
43.44
42.47
854K -1.87%
Aug 16, 2023 43.29 43.89
43.89
43.01
621K -1.66%
Aug 15, 2023 44.02 43.92
44.12
43.43
677K 0.36%
Aug 14, 2023 43.86 43.72
44.24
43.25
628K 0.25%
Aug 11, 2023 43.75 43.8
44.03
43.35
934K -0.64%
Aug 10, 2023 44.03 42.88
45
42.87
906K 3.28%
Aug 9, 2023 42.63 42.42
44.79
41.51
1.3M -1.57%
Aug 8, 2023 43.31 42.01
43.6
41.9
1.4M 3.09%
Aug 7, 2023 42.01 42.64
42.64
41.65
1.3M -0.94%
Aug 4, 2023 42.41 42.12
43.12
41.94
698K 0.74%
Aug 3, 2023 42.1 42.82
43.36
41.87
961K -1.75%
Aug 2, 2023 42.85 42.03
42.91
41.62
1.0M 1.35%
Aug 1, 2023 42.28 43.07
43.65
42.22
874K -1.58%
Jul 31, 2023 42.96 43.68
43.99
42.56
1.2M -1.6%
Jul 28, 2023 43.66 43.6
44.24
43.16
1.0M 0.34%
Jul 27, 2023 43.51 43.91
44.16
43.18
1.1M -0.55%
Jul 26, 2023 43.75 42.8
44.1
42.28
1.0M 2.20%
Jul 25, 2023 42.81 42.58
43.49
42.41
1.1M 0.12%
Jul 24, 2023 42.76 42.72
43.41
42.48
1.3M -0.3%
Jul 21, 2023 42.89 43.05
43.32
42.4
1.1M 0.75%
Jul 20, 2023 42.57 42.01
42.73
41.38
1.2M 1.38%
Jul 19, 2023 41.99 41.81
42.46
41.27
1.4M 0.70%
Jul 18, 2023 41.7 40.28
42.32
40.1
1.7M 3.55%
Jul 17, 2023 40.27 38.74
41.56
38.36
2.6M 0%